Certified by Founder Lodge
Nimbus Therapeutics
United States - Cambridge, Massachusetts
START UP
1 Disclosed Funding Rounds $125,000,000
0 Participating Investments
-
Founded date
2009
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
At Nimbus, we design breakthrough medicines. Utilizing our powerful structure-based drug discovery engine, we create potent and selective small molecule compounds targeting proteins that are
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 13 ,2022 | Unknown | $125,000,000 |
Bain Capital
Atlas Venture
SV Health Investors
Pfizer
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Onsetto | $2,200,000 | (Jan 13, 2026)
Diagonal Therapeutics | $125,000,000 | (Jan 13, 2026)
BlueNalu | $11,000,000 | (Jan 13, 2026)
encoord | $2,000,000 | (Jan 13, 2026)
Vibrant Therapeutics | $61,000,000 | (Jan 13, 2026)
